Sun L, Zhang J, Xiahou Z, Zhao Z, Liang Y
Front Immunol. 2025; 15:1506225.
PMID: 39936154
PMC: 11810940.
DOI: 10.3389/fimmu.2024.1506225.
Becktell K, Chen Y, Yasui Y, Phelan R, Armstrong G, Link M
Pediatr Blood Cancer. 2024; 71(10):e31189.
PMID: 39010279
PMC: 11343645.
DOI: 10.1002/pbc.31189.
Rajan S, Hindiskere S, Chinder P
Indian J Surg Oncol. 2024; 15(Suppl 1):106-111.
PMID: 38545579
PMC: 10963696.
DOI: 10.1007/s13193-023-01755-3.
Halalsheh H, Abu-Hijlih R, Ismael T, Shehadeh A, Salaymeh K, Boheisi M
South Asian J Cancer. 2023; 12(3):290-296.
PMID: 38047045
PMC: 10691917.
DOI: 10.1055/s-0042-1760203.
Basit Q, Qazi H, Tanveer S
Cancer Treat Res. 2023; 185:127-139.
PMID: 37306908
DOI: 10.1007/978-3-031-27156-4_8.
Establishment, Maintenance, and Performance of the Cooperative Osteosarcoma Study Group (COSS).
Bielack S, Kager L, Kuhne T, Langer T, Reichardt P, Blattmann C
Cancers (Basel). 2023; 15(5).
PMID: 36900310
PMC: 10000534.
DOI: 10.3390/cancers15051520.
Development and Validation of Nomograms to Assess Risk Factors and Overall Survival Prediction for Lung Metastasis in Young Patients with Osteosarcoma: A SEER-Based Study.
Liu Z, Li G, Liu H, Zhu J, Wang D
Int J Clin Pract. 2022; 2022:8568724.
PMID: 36380749
PMC: 9626197.
DOI: 10.1155/2022/8568724.
Non-coding RNAs in drug and radiation resistance of bone and soft-tissue sarcoma: a systematic review.
Chen H, Zhang T, Zhang F, Zhang T
Elife. 2022; 11.
PMID: 36326232
PMC: 9691005.
DOI: 10.7554/eLife.79655.
Fifty years of bone tumors.
Bartelstein M, Boland P
J Surg Oncol. 2022; 126(5):906-912.
PMID: 36087079
PMC: 9524618.
DOI: 10.1002/jso.27027.
A population-based analysis of the presentation and outcomes of pediatric patients with osteosarcoma in Canada: a report from CYP-C.
Horkoff M, Kendal J, Blackmore C, Truong T, Guilcher G, Brindle M
Can J Surg. 2022; 65(4):E527-E533.
PMID: 35961660
PMC: 9377546.
DOI: 10.1503/cjs.008220.
Origin and Therapies of Osteosarcoma.
Moukengue B, Lallier M, Marchandet L, Baudhuin M, Verrecchia F, Ory B
Cancers (Basel). 2022; 14(14).
PMID: 35884563
PMC: 9322921.
DOI: 10.3390/cancers14143503.
LncRNA RUSC1-AS1 promotes osteosarcoma progression through regulating the miR-340-5p and PI3K/AKT pathway.
Tong C, Deng Q, Ou D, Long X, Liu H, Huang K
Aging (Albany NY). 2021; 13(16):20116-20130.
PMID: 34048366
PMC: 8436931.
DOI: 10.18632/aging.203047.
Targeting Molecular Mechanisms Underlying Treatment Efficacy and Resistance in Osteosarcoma: A Review of Current and Future Strategies.
Lilienthal I, Herold N
Int J Mol Sci. 2020; 21(18).
PMID: 32961800
PMC: 7555161.
DOI: 10.3390/ijms21186885.
Adjuvant and Neoadjuvant Chemotherapy for Osteosarcoma: A Historical Perspective.
Benjamin R
Adv Exp Med Biol. 2020; 1257:1-10.
PMID: 32483726
DOI: 10.1007/978-3-030-43032-0_1.
Quantification of Osteosarcoma Mineralization on Plain Radiographs - Novel Software Applications to Assess Response to Chemotherapy.
Xu X, Samkoe K, Anderson M, Henderson E
Proc SPIE Int Soc Opt Eng. 2020; 11224.
PMID: 32483398
PMC: 7263182.
DOI: 10.1117/12.2546954.
Methotrexate, doxorubicin, and cisplatinum regimen is still the preferred option for osteosarcoma chemotherapy: A meta-analysis and clinical observation.
Yu D, Zhang S, Feng A, Xu D, Zhu Q, Mao Y
Medicine (Baltimore). 2019; 98(19):e15582.
PMID: 31083238
PMC: 6531127.
DOI: 10.1097/MD.0000000000015582.
Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial.
Marina N, Smeland S, Bielack S, Bernstein M, Jovic G, Krailo M
Lancet Oncol. 2016; 17(10):1396-1408.
PMID: 27569442
PMC: 5052459.
DOI: 10.1016/S1470-2045(16)30214-5.
Potentiation of the antitumor activity of adriamycin against osteosarcoma by cannabinoid WIN-55,212-2.
Niu F, Zhao S, Xu C, Sha H, Bi G, Chen L
Oncol Lett. 2015; 10(4):2415-2421.
PMID: 26622862
PMC: 4580018.
DOI: 10.3892/ol.2015.3525.
Species differences in tumour responses to cancer chemotherapy.
Lawrence J, Cameron D, Argyle D
Philos Trans R Soc Lond B Biol Sci. 2015; 370(1673).
PMID: 26056373
PMC: 4581034.
DOI: 10.1098/rstb.2014.0233.
RPN2 Gene Confers Osteosarcoma Cell Malignant Phenotypes and Determines Clinical Prognosis.
Fujiwara T, Takahashi R, Kosaka N, Nezu Y, Kawai A, Ozaki T
Mol Ther Nucleic Acids. 2014; 3:e189.
PMID: 25181275
PMC: 4222647.
DOI: 10.1038/mtna.2014.35.
